Routine screening MRI for spinal cord compression in prostate cancer ‘not warranted’
The first multi-centre RCT in men with castration-resistant metastatic prostate cancer finds there's no survival benefit with the intervention.
…The first multi-centre RCT in men with castration-resistant metastatic prostate cancer finds there's no survival benefit with the intervention.
…Researchers have quantified the survival benefit of adjuvant radiotherapy after radical prostatectomy compared with early salvage radiotherapy.
…The ARASENS trial provides compelling evidence for adjunctive use of the drug with metastatic disease, researchers say.
US research shows some surgeons see 40% of their patients regain their former sexual function at 12 months, while others see none.
Better support and education is needed so patients have realistic expectations, researchers say.
Danish study shows excess risk for a number of cancers in men and women three month after an acute urinary retention diagnosis: BMJ.
Observational research shows survival in men with COVID-19 who are on androgen deprivation therapy is the same as those who aren't.
The higher dose but shorter duration approach has similar levels of side-effects to conventional dosing, US researchers say.
First results from the international IMPACT study suggest two pathogenic gene variants put carriers at increased risk.
Final results of the ACIS study in patients with castration-resistant disease show a benefit in radiographic progression-free survival.
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.